- Home
- SQFT vs NCNA Comparison
SQFT vs NCNA Comparison
Compare SQFT & NCNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SQFT
- NCNA
- Stock Information
- Founded
- SQFT 1999
- NCNA 1997
- Country
- SQFT United States
- NCNA United Kingdom
- Employees
- SQFT N/A
- NCNA N/A
- Industry
- SQFT Real Estate Investment Trusts
- NCNA Biotechnology: Pharmaceutical Preparations
- Sector
- SQFT Real Estate
- NCNA Health Care
- Exchange
- SQFT Nasdaq
- NCNA Nasdaq
- Market Cap
- SQFT 7.7M
- NCNA 6.6M
- IPO Year
- SQFT 2020
- NCNA 2017
- Fundamental
- Price
- SQFT $7.28
- NCNA $3.99
- Analyst Decision
- SQFT
- NCNA
- Analyst Count
- SQFT 0
- NCNA 0
- Target Price
- SQFT N/A
- NCNA N/A
- AVG Volume (30 Days)
- SQFT 947.3K
- NCNA 438.2K
- Earning Date
- SQFT 11-11-2025
- NCNA 08-20-2025
- Dividend Yield
- SQFT N/A
- NCNA N/A
- EPS Growth
- SQFT N/A
- NCNA N/A
- EPS
- SQFT N/A
- NCNA N/A
- Revenue
- SQFT $18,052,597.00
- NCNA N/A
- Revenue This Year
- SQFT $23.63
- NCNA N/A
- Revenue Next Year
- SQFT N/A
- NCNA N/A
- P/E Ratio
- SQFT N/A
- NCNA N/A
- Revenue Growth
- SQFT N/A
- NCNA N/A
- 52 Week Low
- SQFT $4.19
- NCNA $2.78
- 52 Week High
- SQFT $23.00
- NCNA $816.00
- Technical
- Relative Strength Index (RSI)
- SQFT 62.88
- NCNA 43.75
- Support Level
- SQFT $5.36
- NCNA $3.94
- Resistance Level
- SQFT $10.47
- NCNA $4.88
- Average True Range (ATR)
- SQFT 0.62
- NCNA 0.32
- MACD
- SQFT 0.34
- NCNA 0.43
- Stochastic Oscillator
- SQFT 45.47
- NCNA 57.62
About SQFT Presidio Property Trust Inc.
Presidio Property Trust Inc is an internally managed, diversified REIT with holdings in model home properties which are triple-net leased to homebuilders, office, industrial, and retail properties. Presidio's model homes are leased to homebuilders located in Arizona, Illinois, Texas, Wisconsin, and Florida. The office, industrial and retail properties are located in Colorado, with properties also located in Maryland, North Dakota, Texas, and Southern California.
About NCNA NuCana plc
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.